CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
20.34
3.91%
Market Trading Hours* (UTC) Open now
Closes on Friday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.18
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Artivion Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 21.25
Open* 20.98
1-Year Change* 55.75%
Day's Range* 20.39 - 20.98
52 wk Range 11.44-19.00
Average Volume (10 days) 197.93K
Average Volume (3 months) 4.64M
Market Cap 737.23M
P/E Ratio -100.00K
Shares Outstanding 41.05M
Revenue 339.73M
EPS -0.60
Dividend (Yield %) N/A
Beta 1.64
Next Earnings Date Feb 14, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 11, 2024 21.25 0.09 0.43% 21.16 21.50 21.15
Apr 10, 2024 21.39 0.72 3.48% 20.67 21.48 20.67
Apr 9, 2024 21.56 -0.07 -0.32% 21.63 21.69 21.32
Apr 8, 2024 21.54 0.48 2.28% 21.06 21.62 20.96
Apr 5, 2024 21.27 0.31 1.48% 20.96 21.48 20.96
Apr 4, 2024 21.21 0.00 0.00% 21.21 21.71 21.13
Apr 3, 2024 21.35 1.87 9.60% 19.48 21.37 19.48
Apr 2, 2024 20.71 0.08 0.39% 20.63 20.74 20.30
Apr 1, 2024 21.02 0.04 0.19% 20.98 21.27 20.65
Mar 28, 2024 21.02 -0.37 -1.73% 21.39 21.73 21.01
Mar 27, 2024 21.56 0.96 4.66% 20.60 21.65 20.60
Mar 26, 2024 20.46 0.49 2.45% 19.97 20.54 19.85
Mar 25, 2024 19.97 -0.31 -1.53% 20.28 20.68 19.92
Mar 22, 2024 20.34 -0.30 -1.45% 20.64 20.82 20.25
Mar 21, 2024 20.94 0.33 1.60% 20.61 21.37 20.47
Mar 20, 2024 20.64 0.83 4.19% 19.81 20.99 19.81
Mar 19, 2024 20.28 0.55 2.79% 19.73 20.38 19.60
Mar 18, 2024 19.84 0.21 1.07% 19.63 19.96 19.43
Mar 15, 2024 19.65 0.05 0.26% 19.60 19.92 18.97
Mar 14, 2024 20.03 0.60 3.09% 19.43 20.12 18.95

Artivion Inc Events

Time (UTC) Country Event
Thursday, May 2, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Artivion Inc Earnings Release
Q1 2024 Artivion Inc Earnings Release

Forecast

-

Previous

-
Tuesday, May 14, 2024

Time (UTC)

13:00

Country

US

Event

Artivion Inc Annual Shareholders Meeting
Artivion Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, May 15, 2024

Time (UTC)

13:00

Country

US

Event

Artivion Inc Annual Shareholders Meeting
Artivion Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, August 1, 2024

Time (UTC)

10:59

Country

US

Event

Q2 2024 Artivion Inc Earnings Release
Q2 2024 Artivion Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 313.789 298.836 253.227 276.222 262.841
Revenue 313.789 298.836 253.227 276.222 262.841
Cost of Revenue, Total 111.266 101.322 85.443 93.209 89.857
Gross Profit 202.523 197.514 167.784 183.013 172.984
Total Operating Expense 307.588 307.116 250.786 259.18 253.529
Selling/General/Admin. Expenses, Total 149.315 131.358 121.172 128.061 122.382
Research & Development 38.879 35.546 24.207 22.96 23.098
Unusual Expense (Income) -7.7 21.474 6.2 4.1 7.4
Operating Income 6.201 -8.28 2.441 17.042 9.312
Interest Income (Expense), Net Non-Operating -21.177 -21.834 -16.481 -14.148 -15.562
Other, Net -0.008 -0.636 -3.134 -1.25 -0.141
Net Income Before Taxes -14.984 -14.827 -17.174 1.644 -6.391
Net Income After Taxes -19.192 -14.834 -16.682 1.565 -3.078
Net Income Before Extra. Items -19.192 -14.834 -16.682 1.565 -3.078
Net Income -19.192 -14.834 -16.682 1.72 -2.84
Total Adjustments to Net Income 0.098 0.094 0.111 -0.012 0.027
Income Available to Common Excl. Extra. Items -19.094 -14.74 -16.571 1.553 -3.051
Income Available to Common Incl. Extra. Items -19.094 -14.74 -16.571 1.708 -2.813
Dilution Adjustment
Diluted Net Income -19.094 -14.74 -16.571 1.708 -2.813
Diluted Weighted Average Shares 40.032 38.983 37.861 37.86 36.412
Diluted EPS Excluding Extraordinary Items -0.47697 -0.37811 -0.43768 0.04102 -0.08379
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -0.60199 -0.28556 -0.30205 0.14411 0.04831
Total Extraordinary Items 0.155 0.238
Depreciation / Amortization 15.828 17.416 13.764 10.85 10.792
Gain (Loss) on Sale of Assets 0 15.923
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 89.251 83.229 79.398 76.838 80.34
Revenue 89.251 83.229 79.398 76.838 80.34
Cost of Revenue, Total 31.167 29.502 28.51 28.094 28.168
Gross Profit 58.084 53.727 50.888 48.744 52.172
Total Operating Expense 95.826 87.09 75.268 80.944 75.799
Selling/General/Admin. Expenses, Total 64.403 51.352 38.596 36.374 38.047
Research & Development 7.418 7.223 8.304 11.799 8.648
Depreciation / Amortization 3.938 4.013 3.758 3.813 4.036
Unusual Expense (Income) -11.1 -5 -3.9 0.864 -3.1
Operating Income -6.575 -3.861 4.13 -4.106 4.541
Interest Income (Expense), Net Non-Operating -6.091 -6.021 -5.309 -4.765 -4.071
Other, Net -4.241 0.963 4.456 -3.661 -3.77
Net Income Before Taxes -2.657 -8.919 3.277 -12.532 -3.3
Net Income After Taxes -3.382 -13.532 2.169 -13.713 -4.259
Net Income Before Extra. Items -3.382 -13.532 2.169 -13.713 -4.259
Net Income -3.382 -13.532 2.169 -13.713 -4.259
Total Adjustments to Net Income 0.012 0.056 -0.011 0.07 0.021
Income Available to Common Excl. Extra. Items -3.37 -13.476 2.158 -13.643 -4.238
Income Available to Common Incl. Extra. Items -3.37 -13.476 2.158 -13.643 -4.238
Diluted Net Income -3.37 -13.476 2.158 -13.643 -4.238
Diluted Weighted Average Shares 40.755 40.675 40.131 40.115 40.031
Diluted EPS Excluding Extraordinary Items -0.08269 -0.33131 0.05377 -0.3401 -0.10587
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.487 -0.41121 -0.00939 -0.3261 -0.1562
Gain (Loss) on Sale of Assets 14.25 0 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 247.334 247.697 234.589 187.39 179.168
Cash and Short Term Investments 39.351 55.01 61.412 33.766 41.489
Cash & Equivalents 39.351 55.01 61.412 33.766 41.489
Total Receivables, Net 69.584 58.105 48.752 55.861 51.432
Accounts Receivable - Trade, Net 61.82 53.019 45.964 52.94 47.108
Total Inventory 74.478 76.971 73.038 53.071 45.478
Prepaid Expenses 17.55 14.748 14.295 11.613 6.848
Other Current Assets, Total 46.371 42.863 37.092 33.079 33.921
Total Assets 762.798 793.052 789.404 605.654 571.091
Property/Plant/Equipment, Total - Net 80.533 83.235 51.648 54.144 31.028
Property/Plant/Equipment, Total - Gross 183.073 177.76 138.825 130.101 95.598
Accumulated Depreciation, Total -102.54 -94.525 -87.177 -75.957 -64.57
Goodwill, Net 243.631 250 260.061 186.697 188.781
Intangibles, Net 182.647 201.496 227.057 157.734 160.081
Other Long Term Assets, Total 8.653 10.624 16.049 19.689 12.033
Total Current Liabilities 49.675 44.953 60.468 45.195 34.523
Accounts Payable 12.004 10.395 9.623 9.796 7.547
Accrued Expenses 31.603 27.688 27.046 28.842 21.234
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2.121 2.158 1.809 1.761 1.889
Other Current Liabilities, Total 3.947 4.712 21.99 4.796 3.853
Total Liabilities 478.469 492.324 460.691 319.958 296.024
Total Long Term Debt 310.143 311.867 295.768 219.986 221.658
Long Term Debt 306.499 307.493 290.468 214.571 215.721
Other Liabilities, Total 94.152 106.705 69.742 28.933 12.576
Total Equity 284.329 300.728 328.713 285.696 275.067
Common Stock 0.418 0.414 0.404 0.39 0.385
Additional Paid-In Capital 337.385 322.874 316.192 271.782 260.361
Retained Earnings (Accumulated Deficit) -17.217 1.975 20.022 36.704 34.984
Treasury Stock - Common -14.648 -14.648 -14.648 -14.591 -14.591
Other Equity, Total -21.609 -9.887 6.743 -8.589 -6.072
Total Liabilities & Shareholders’ Equity 762.798 793.052 789.404 605.654 571.091
Total Common Shares Outstanding 40.343 39.91 38.907 37.534 36.979
Capital Lease Obligations 3.644 4.374 5.3 5.415 5.937
Deferred Income Tax 24.499 28.799 34.713 25.844 27.267
Redeemable Preferred Stock 0 0 0
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 267.109 263.898 240.681 247.334 237.989
Cash and Short Term Investments 53.481 48.775 30.773 39.351 37.572
Cash & Equivalents 53.481 48.775 30.773 39.351 37.572
Total Receivables, Net 68.27 69.256 66.712 69.584 65.039
Accounts Receivable - Trade, Net 64.277 64.806 62.76 61.82 57.159
Total Inventory 78.792 78.458 76.273 74.478 73.044
Prepaid Expenses 17.175 19.107 19.508 17.55 16.851
Other Current Assets, Total 49.391 48.302 47.415 46.371 45.483
Total Assets 774.787 777.861 757.073 762.798 742.731
Property/Plant/Equipment, Total - Net 80.773 79.214 80.189 80.533 77.606
Property/Plant/Equipment, Total - Gross 59.975 56.773 56.61 56.061 55.405
Accumulated Depreciation, Total -16.63 -15.948 -15.137 -14.202 -14.085
Goodwill, Net 242.936 245.561 245.648 243.631 234.773
Intangibles, Net 172.073 176.995 180.64 182.647 179.172
Other Long Term Assets, Total 11.896 12.193 9.915 8.653 13.191
Total Current Liabilities 54.959 56.23 43.961 49.675 45.992
Accounts Payable 10.819 10.455 9.473 12.004 10.721
Accrued Expenses 29.591 28.938 24.259 31.603 26.53
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.552 1.561 1.62 2.121 1.562
Other Current Liabilities, Total 12.997 15.276 8.609 3.947 7.179
Total Liabilities 502.812 495.353 477.156 478.469 487.623
Total Long Term Debt 309.149 309.555 309.861 310.143 310.124
Long Term Debt 305.877 306.109 306.279 306.499 306.674
Capital Lease Obligations 3.272 3.446 3.582 3.644 3.45
Deferred Income Tax 19.514 19.469 23.826 24.499 34.058
Other Liabilities, Total 119.19 110.099 99.508 94.152 97.449
Total Equity 271.975 282.508 279.917 284.329 255.108
Common Stock 0.425 0.424 0.424 0.418 0.418
Additional Paid-In Capital 351.307 347.03 342.883 337.385 334.077
Retained Earnings (Accumulated Deficit) -43.932 -34.131 -30.749 -17.217 -19.386
Treasury Stock - Common -14.648 -14.648 -14.648 -14.648 -14.648
Other Equity, Total -21.177 -16.167 -17.993 -21.609 -45.353
Total Liabilities & Shareholders’ Equity 774.787 777.861 757.073 762.798 742.731
Total Common Shares Outstanding 41.05 40.956 40.879 40.343 40.329
Redeemable Preferred Stock 0 0 0 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -19.192 -14.834 -16.682 1.72 -2.84
Cash From Operating Activities -5.153 -2.585 12.369 15.827 9.881
Cash From Operating Activities 22.442 23.977 20.712 18.317 18.095
Deferred Taxes -1.717 -4.47 4.283 -2.305 -4.485
Non-Cash Items 19.25 25.974 30.752 17.478 9.123
Cash Taxes Paid 9.244 5.483 4.122 1.944 1.699
Cash Interest Paid 14.243 14.407 13.049 13.297 15.005
Changes in Working Capital -25.936 -33.232 -26.696 -19.383 -10.012
Cash From Investing Activities -10.715 5.66 -73.128 -23.943 -6.715
Capital Expenditures -10.715 -13.091 -7.328 -8.072 -5.786
Other Investing Cash Flow Items, Total 0 18.751 -65.8 -15.871 -0.929
Cash From Financing Activities -1.639 -12.223 93.608 -1.493 -2.562
Financing Cash Flow Items -0.459 -10.98 -1.483 -0.728 -1.526
Issuance (Retirement) of Stock, Net 1.573 1.842 0.437 2.015 1.754
Issuance (Retirement) of Debt, Net -2.753 -3.085 94.654 -2.78 -2.79
Foreign Exchange Effects 1.848 2.2 -5.185 1.667 0.879
Net Change in Cash -15.659 -6.948 27.664 -7.942 1.483
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -13.532 -19.192 -21.361 -7.648 -3.389
Cash From Operating Activities -6.154 -5.153 -4.936 -8.912 -0.598
Cash From Operating Activities 5.734 22.442 17.016 11.497 5.881
Deferred Taxes -2.167 -1.717 5.097 -1.611 -2.966
Non-Cash Items 11.82 19.25 14.884 8.02 4.771
Changes in Working Capital -8.009 -25.936 -20.572 -19.17 -4.895
Cash From Investing Activities -2.843 -10.715 -8.047 -4.994 -2.708
Capital Expenditures -2.238 -10.715 -8.047 -4.055 -2.239
Other Investing Cash Flow Items, Total -0.605 0 0 -0.939 -0.469
Cash From Financing Activities 1.171 -1.639 -0.78 -1.032 -0.235
Financing Cash Flow Items -0.13 -0.459 -0.3 -0.241 -0.129
Issuance (Retirement) of Stock, Net 1.991 1.573 1.553 0.579 0.588
Issuance (Retirement) of Debt, Net -0.69 -2.753 -2.033 -1.37 -0.694
Foreign Exchange Effects -0.752 1.848 -3.675 0.31 -0.061
Net Change in Cash -8.578 -15.659 -17.438 -14.628 -3.602

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Artivion Inc Company profile

About Artivion Inc

Artivion, Inc. (Artivion), formerly CryoLife, Inc., is a medical device company. The Company is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The Company's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. It offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The Company's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Artivion Inc revenues increased 18% to $298.8M. Net loss applicable to common stockholders decreased 11% to $14.7M. Revenues reflect Medical Devices segment increase of 24% to $221.6M, Preservation services segment increase of 4% to $77.2M, International segment increase of 28% to $147.7M, United States segment increase of 9% to $151.2M.

Equity composition

Common Stock $.01 Par, 03/11, 75M auth., 29,950,000 issd., less 2,053,000 shares in Treas. @ $11.7M. Insiders own 6.85% . IPO 2/93, 1.5M shs @ $10 by Robinson-Humphrey. PO 4/98, 2.75M shs (2.513M by Co.) @ $16.50 by SBC Warburg Dillon Read. 12/00, 3-for-2 split; 7/96, 2-for-1 split. FY'01 Qs are restated.

Industry: Medical Equipment, Supplies & Distribution (NEC)

1655 Roberts Boulevard N W
KENNESAW
GEORGIA 30144
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

XRP/USD

0.60 Price
-3.630% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,432.19 Price
-2.780% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,378.99 Price
+0.670% 1D Chg, %
Long position overnight fee -0.0187%
Short position overnight fee 0.0105%
Overnight fee time 21:00 (UTC)
Spread 0.50

US100

18,054.90 Price
-1.330% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading